{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-008006","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.828870+00:00","generated_at":"2026-05-24T23:36:12.536454+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nuwellis Q4 revenue $2.3M (-9% YoY); net loss narrows to $1.5M from $7.9M","bullets":["Q4 revenue $2.3M, down 9% YoY; consumables utilization +21%, critical care revenue +35%.","Gross margin 58.4% vs 54.4% YoY; includes $150K voluntary recall expense.","Operating loss $2.4M, improved from $3.6M; full-year cost reduction $5.9M (-26%).","Net loss attributable to common $1.5M ($0.44/share) vs $7.9M ($54.48/share) YoY.","Cash $5.1M, no debt; CMS payment for Aquadex increased 4x to $1,639 effective Jan 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-008006","json":"https://secwatch.observer/filing/0001140361-25-008006.json","markdown":"https://secwatch.observer/filing/0001140361-25-008006.md","text":"https://secwatch.observer/filing/0001140361-25-008006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125008006/0001140361-25-008006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125008006/ef20045179_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:36:12.536454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}